Hanmi Pharm Reports Operating Loss of 32.2 Billion KRW in Q3... Returns to Deficit

[Asia Economy Reporter Oh Ju-yeon] Hanmi Pharm announced on the 30th that its consolidated operating loss for the third quarter of this year was 32.2 billion KRW, turning to a deficit compared to the same period last year. Sales increased by 0.5% year-on-year to 266.9 billion KRW, and net loss for the period turned to a deficit of 31.2 billion KRW.

This content was produced with the assistance of AI translation services.